Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital (CONNECT)

5. november 2021 opdateret af: BioSerenity

CONNECT: Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital

The proposed study is designed to evaluate the performance of the Neuronaute in comparison with the gold standard EEG in patients with a regular appointment at the hospital. The design of this study is guided by two overriding factors : (i) epileptics disorders suspected or either (ii) epileptics already diagnosed.

Volunteers will be asked to participate to this study. This study will enroll 35 outpatient subjects aged 18 to 85. Informed consent will be obtained from the patients, and assent from the subjects, prior to any form of assessment or intervention as part of the study.

Patients will be submitted to the studied device record Neuronaute following by the gold standard EEG.

A grid with all EEG activity recorded during the trial will be provided for evaluation after completion of the trial.

Studieoversigt

Status

Trukket tilbage

Betingelser

Undersøgelsestype

Interventionel

Fase

  • Ikke anvendelig

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 85 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Patients, with a regular appointment to perform an EEG recording: (i) suspected of epileptic disorders or (ii) epilepsy already diagnosed.
  • Age (> 18 years),
  • Affiliated to the social security
  • Informed consent.

Exclusion Criteria:

  • No informed consent
  • Age (< 18 years)
  • No affiliation to the social security
  • Unsuitable anthropometric parameters
  • Pregnant women
  • Recent brain surgery
  • Wound or scores on the body and the scalp
  • Ongoing participation in another clinical trial
  • Allergy to any component from MD including : Silver, polyamide, silicone
  • Sensory disorders making the patient insensitive to pain on the skin
  • Behavioral disorders making the patient excessively agitated or aggressive;
  • Motor or mental disorders preventing the patient from expressing his or her pain;
  • Cardiorespiratory disorders likely to be aggravated by slight compression of the chest;
  • The susceptibility to tension headaches (the compression exerted by the bonnet may in certain cases trigger a headache)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Diagnostisk
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: GOLD STANDARD
RECORDING WITH EEG GOLD STANDARD
RECORDING WITH EEG GOLDSTANDARD
Eksperimentel: NEURONAUTE
RECORDING WITH THE NEURONAUTE
RECORDING WITH NEURONAUTE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Reproducibility of electroencephalographic signals interpretation recorded by the Neuronaute compared to the gold standard.
Tidsramme: 1 year

The main evaluation criteria is the reproducibility based on the interpretation of electroencephalographic signals recorded by the Neuronaute compared to the gold standard. The system will be considered effective if there are no significant differences in the physiological parameters recorded by the two systems.

A clinical expert will interpret the EEG(electroencephalography) signals and fill the EEG evaluation sheet. It includes items such as signals quality and presence of abnormal events

1 year

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The Neuronaute will be considered effective if it detects inter-critical epileptic abnormalities in at least one patient.
Tidsramme: 1 year
A section of the evaluation sheet is designed for the secondary objectives.
1 year
The Neuronaute will be considered efficient if the installation time is at least as fast as the installation of the gold standard. The time will be measured from the beginning of the patient's preparation until the beginning of the recording.
Tidsramme: 2 hours
The time needed to set up the clinical device and the device under test will be noted in the Case Report Form.
2 hours
The quality of the Neuronaute's ECG signal will be compared with the gold standard using an evaluation grid.
Tidsramme: 1 year
An evaluation grid led to compare the quality of th Neuronaute's ECG signal and Gold Standard' signal
1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Forventet)

20. december 2020

Primær færdiggørelse (Forventet)

20. december 2020

Studieafslutning (Forventet)

20. december 2020

Datoer for studieregistrering

Først indsendt

7. december 2016

Først indsendt, der opfyldte QC-kriterier

19. december 2017

Først opslået (Faktiske)

20. december 2017

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

11. november 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. november 2021

Sidst verificeret

1. december 2020

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • n°2016-A01754-47

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

3
Abonner